Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TANDEM-1: Deferoxamine in Acute Ischemic Stroke
NCT00777140Phase 2Completed
- Sponsor
- Hospital Universitari Germans Trias i Pujol
- Start
- Sep 2008
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in ischemic stroke comparing Deferoxamine with Placebo (2 arms). Primary endpoint: Clinical and Analytical Adverse Events at 3 months. Started Sep 2008; status: completed.
02
Drugs
deferoxamine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00777140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00777140.